188 related articles for article (PubMed ID: 14670583)
1. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate.
Jenssen H; Andersen JH; Uhlin-Hansen L; Gutteberg TJ; Rekdal Ø
Antiviral Res; 2004 Feb; 61(2):101-9. PubMed ID: 14670583
[TBL] [Abstract][Full Text] [Related]
2. Modelling of anti-HSV activity of lactoferricin analogues using amino acid descriptors.
Jenssen H; Gutteberg TJ; Lejon T
J Pept Sci; 2005 Feb; 11(2):97-103. PubMed ID: 15635641
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin.
Jenssen H; Sandvik K; Andersen JH; Hancock RE; Gutteberg TJ
Antiviral Res; 2008 Sep; 79(3):192-8. PubMed ID: 18456345
[TBL] [Abstract][Full Text] [Related]
4. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.
Andersen JH; Jenssen H; Gutteberg TJ
Antiviral Res; 2003 May; 58(3):209-15. PubMed ID: 12767468
[TBL] [Abstract][Full Text] [Related]
5. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface.
Andersen JH; Jenssen H; Sandvik K; Gutteberg TJ
J Med Virol; 2004 Oct; 74(2):262-71. PubMed ID: 15332275
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans.
Marchetti M; Trybala E; Superti F; Johansson M; Bergström T
Virology; 2004 Jan; 318(1):405-13. PubMed ID: 14972565
[TBL] [Abstract][Full Text] [Related]
7. A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus.
Jenssen H; Andersen JH; Mantzilas D; Gutteberg TJ
Antiviral Res; 2004 Nov; 64(2):119-26. PubMed ID: 15498607
[TBL] [Abstract][Full Text] [Related]
8. Small lytic peptides escape the inhibitory effect of heparan sulfate on the surface of cancer cells.
Fadnes B; Uhlin-Hansen L; Lindin I; Rekdal Ø
BMC Cancer; 2011 Mar; 11():116. PubMed ID: 21453492
[TBL] [Abstract][Full Text] [Related]
9. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1.
Marr AK; Jenssen H; Moniri MR; Hancock RE; Panté N
Biochimie; 2009 Jan; 91(1):160-4. PubMed ID: 18573311
[TBL] [Abstract][Full Text] [Related]
10. Anti herpes simplex virus activity of lactoferrin/lactoferricin -- an example of antiviral activity of antimicrobial protein/peptide.
Jenssen H
Cell Mol Life Sci; 2005 Dec; 62(24):3002-13. PubMed ID: 16261265
[TBL] [Abstract][Full Text] [Related]
11. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection.
Siciliano R; Rega B; Marchetti M; Seganti L; Antonini G; Valenti P
Biochem Biophys Res Commun; 1999 Oct; 264(1):19-23. PubMed ID: 10527833
[TBL] [Abstract][Full Text] [Related]
12. Lactoferricin derived from milk protein lactoferrin.
Wakabayashi H; Takase M; Tomita M
Curr Pharm Des; 2003; 9(16):1277-87. PubMed ID: 12769736
[TBL] [Abstract][Full Text] [Related]
13. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.
Tiwari V; Liu J; Valyi-Nagy T; Shukla D
J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749
[TBL] [Abstract][Full Text] [Related]
14. Binding of a N,N'-bisheteryl derivative of dispirotripiperazine to heparan sulfate residues on the cell surface specifically prevents infection of viruses from different families.
Schmidtke M; Karger A; Meerbach A; Egerer R; Stelzner A; Makarov V
Virology; 2003 Jun; 311(1):134-43. PubMed ID: 12832211
[TBL] [Abstract][Full Text] [Related]
15. Bovine and human lactoferricin peptides: chimeras and new cyclic analogs.
Arias M; McDonald LJ; Haney EF; Nazmi K; Bolscher JG; Vogel HJ
Biometals; 2014 Oct; 27(5):935-48. PubMed ID: 24916114
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody against bovine Lactoferricin and its epitopic site.
Shimazaki K; Nam MS; Harakawa S; Tanaka T; Omata Y; Saito A; Kumura H; Mikawa K; Igarashi I; Suzuki N
J Vet Med Sci; 1996 Dec; 58(12):1227-9. PubMed ID: 8996707
[TBL] [Abstract][Full Text] [Related]
17. Direct detection and quantitative determination of bovine lactoferricin and lactoferrin fragments in human gastric contents by affinity mass spectrometry.
Kuwata H; Yip TT; Yip CL; Tomita M; Hutchens TW
Adv Exp Med Biol; 1998; 443():23-32. PubMed ID: 9781339
[TBL] [Abstract][Full Text] [Related]
18. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein.
Chien YJ; Chen WJ; Hsu WL; Chiou SS
Virology; 2008 Sep; 379(1):143-51. PubMed ID: 18640695
[TBL] [Abstract][Full Text] [Related]
19. Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells.
Ammendolia MG; Marchetti M; Superti F
Antiviral Res; 2007 Dec; 76(3):252-62. PubMed ID: 17881064
[TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin.
Marchetti M; Ammendolia MG; Superti F
Biochimie; 2009 Jan; 91(1):155-9. PubMed ID: 18534197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
